Campbell & Co. Investment Adviser »

Crinetics Pharmaceuticals In shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.9M 64k 29.74
2023-06-30 $389k 22k 18.02

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Crinetics Pharmaceuticals In

BlackRock
Point72 Asset Management
FMR
EcoR1 Capital
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Paradigm Biocapital Advisors
Jennison Associates
T. Rowe Price Investment Management
Henderson Group
First Light Asset Management
Perceptive Advisors
Geode Capital Management
Artal Group

View all funds holding Crinetics Pharmaceuticals In